Key Financial Data Of Reporting Company

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7734955

Concept As at
2017-06-30
2017-04-01 to
2017-06-30
2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2016-06-30
2016-04-01 to
2016-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
24,967,000,000 JPY
101,479,000,000 JPY
26,228,000,000 JPY
Ordinary profit (loss)
7,813,000,000 JPY
30,981,000,000 JPY
8,217,000,000 JPY
Net assets
104,101,000,000 JPY
102,655,000,000 JPY
90,053,000,000 JPY
Total assets
138,909,000,000 JPY
135,060,000,000 JPY
129,410,000,000 JPY
Basic earnings (loss) per share
133.81
536.70
140.05
Diluted earnings per share
Equity-to-asset ratio
0.749 xbrli:pure
0.760 xbrli:pure
0.696 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.